UK consortium to help accelerate adoption of low carbon medicines manufacturing

A new UK-based consortium, led by Exactmer, with strategic support from GSK, has been awarded over £7 million in funding from Innovate UK in partnership with the Department of Health and Social Care (DHSC), to advance the production of high purity bio-based solvents for medicines manufacturing.

The 36-month project aims to bolster the UK’s leadership in sustainable pharmaceutical manufacturing and accelerate the scale up of bio-based solvents for low carbon medicine manufacturing.

Consortium members include:

• Technology providers – Exactmer, Queen Mary University London, Atmospheric AI and SOLVE Chemistry

• Solvent manufacturers – OXCCU, Celtic Renewables and University of Leeds

• Global pharmaceutical companies – GSK and Croda

• Global life sciences company – Cytiva

• Translational research and innovation organisation – CPI

Read more